関連する実験動画
Updated: Sep 13, 2025

07:56
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
22.1K
CRISPR-Cas配列をモデル化して高度に機能するゲノムエディターの設計
Jeffrey A Ruffolo1, Stephen Nayfach1, Joseph Gallagher1
1Profluent Bio, Berkeley, CA, USA.
Nature
|July 31, 2025
まとめ
人工知能は新しい遺伝子エディタ OpenCRISPR-1 を設計し 精密なヒトゲノム編集を可能にしました このAIで生成されたツールは既存のCRISPRシステムと同等またはそれよりも優れた性能を示し,ベース編集と互換性があります.
科学分野:
- ゲノミクス
- バイオテクノロジー
- 人工知能
背景:
- CRISPRの遺伝子エディタは 人間の細胞のような 非ネイティブ環境では 限界に直面します
- 進化上の制約により 自然に由来する遺伝子編集ツールの最適化が制限されています
研究 の 目的:
- 人工知能によって設計された新しい遺伝子エディタを 開発する
- 自然に発生するCRISPRシステムの限界をAI主導の設計で克服する
主な方法:
- 多様なゲノムとメタゲノムデータから 100万以上のCRISPRオペロンで大規模な言語モデルを訓練した.
- 新しい Cas9 型のエフェクタータンパク質と 単一ガイド RNA 配列を生成した.
- アクティビティ,特異性,およびベース編集の互換性について,AIによって生成されたエディタを評価した.
主要な成果:
- 精密なヒトゲノム編集のためのAI設計の遺伝子エディターであるOpenCRISPR-1を開発した.
- CRISPR-Casファミリーでは 自然に存在するタンパク質の 4.8倍もの数のクラスターが生成されました
- いくつかのAI設計のエディターは,重要なシーケンスの相違にもかかわらず,SpCas9の性能に匹敵し,またはそれを上回りました.
結論:
- AI主導のデザインは 進化の制約を回避して 最適化された遺伝子編集ツールを作ることができます
- OpenCRISPR-1は強力で プログラム可能で 汎用的な遺伝子編集プラットフォームです
- OpenCRISPR-1のリリースは,研究と商用アプリケーションにおける倫理的進歩を促進します.
関連する概念動画
CRISPR/Cas9 Genome Editing
252
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
252
CRISPR
52.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.9K
CRISPR and crRNAs
17.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.4K
Homologous Recombination
52.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
52.2K
Conservative Site-specific Recombination and Phase Variation
6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.1K

